COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Auto Summaries -
Immunology
Last updated: 2024 Apr 18
Total hit(s): 27816
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Auto Summary
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
38353267
Ethical concerns regarding heterologous COVID-19 vaccine administration.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38593300
Immunogenicity of COVID-19 vaccines in patients with cirrhosis: Expected advantage for additional dose of vaccine.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38501434
Politics and confidence toward the COVID-19 vaccination: Points to be considered.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
4
38626299
Enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in eastern China during the COVID-19 pandemic.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
5
38362044
SARS-CoV-2 triggers Dickkopf-1 (Dkk-1) modulation of T helper cells and lung pathology in mice.
N/A
Genes Dis
2024 Jul
- n/a -
1
6
38515937
Neutralization of SARS-CoV-2 infection by antibodies targeting diverse epitopes.
N/A
Genes Dis
2024 Jul
- n/a -
1
7
38630512
Emulating a Target Trial of Interventions Initiated During Pregnancy With Healthcare Databases: The Example of COVID-19 Vaccination. The Authors Respond.
N/A
Epidemiology
2024 May 1
4.65
1
8
38564917
Sleep, work features, and SARS-cov-2 vaccine antibody response: Comment.
N/A
Sleep Med
2024 May
5.1
1
9
38593858
Heparin-induced Thrombocytopenia with Thrombosis in COVID-19 versus Vaccine-induced Immune Thrombocytopenia and Thrombosis in the United Kingdom.
N/A
Semin Thromb Hemost
2024 Apr 9
6.7
1
10
38587478
School-based mobile clinics to improve vaccine access: a cross-sectional study of COVID-19 vaccination.
N/A
J Pediatric Infect Dis Soc
2024 Apr 8
2.17
1
11
38577792
Prior respiratory syncytial viral infection contributes to severe COVID-19 illness: A nationwide cohort study.
N/A
Allergy
2024 Apr 5
8.7
1
12
38628031
Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S.
N/A
Eur J Neurol
2024 Apr 16
4.3
1
13
38627048
Immune thrombocytopaenic purpura following COVID-19 infection masquerading as senile purpura.
N/A
BMJ Case Rep
2024 Apr 16
0.44
1
14
38631955
Erratum to "Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model" [Vaccine 42(6) (2024) 1292-1299].
N/A
Vaccine
2024 Apr 16
3.31
1
15
38623031
Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic.
N/A
Eur J Neurol
2024 Apr 15
4.3
1
16
38619537
Correction to: Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients.
N/A
Clin Infect Dis
2024 Apr 15
7.71
1
17
38613382
Structural basis for polyuridine tract recognition by SARS-CoV-2 Nsp15.
N/A
Protein Cell
2024 Apr 13
5.52
1
18
38607273
The mouse to man conundrum: Revisiting an old lung injury model to study repurposed drugs for COVID-19 treatment.
N/A
Exp Physiol
2024 Apr 12
4.3
1
19
38614914
Corrigendum to "Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron" [Cytokine Growth Factor Rev. 70 (2023) 13-25].
N/A
Cytokine Growth Factor Rev
2024 Apr 12
5.5
1
20
38607657
Polymyalgia Rheumatica After COVID-19 Vaccination: Data from the EudraVigilance Database.
N/A
Acta Med Port
2024 Apr 12
0.6
1
21
38607645
COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
N/A
JAMA
2024 Apr 12
14.78
1
22
38604913
Addressing vaccine hesitancy: Learning from the successes and failures of the COVID-19 pandemic.
N/A
Vaccine
2024 Apr 10
3.31
1
23
38558035
SARS-CoV-2 spike protein found in the acrosyringium and eccrine gland of repetitive miliaria-like lesions in a woman following mRNA vaccination.
N/A
J Dermatol
2024 Apr 1
4.4
1
24
38452689
Corrigendum to "Extensive transmission of SARS-CoV-2 BQ.1* variant in a population with high levels of hybrid immunity: A prevalence survey" [International Journal of Infectious Diseases 139 (2024) 159-167].
N/A
Int J Infect Dis
2024 Apr
3.42
1
25
38185316
Letter to the Editor regarding Fortier et al: "Common characteristics of shoulder injury related to vaccine administration (SIRVA) following COVID-19 vaccination: a comprehensive systematic review".
N/A
J Shoulder Elbow Surg
2024 Apr
1